HK1218139A1 - 去分化的重新編程細胞所衍生的細胞組合物 - Google Patents

去分化的重新編程細胞所衍生的細胞組合物 Download PDF

Info

Publication number
HK1218139A1
HK1218139A1 HK16106057.9A HK16106057A HK1218139A1 HK 1218139 A1 HK1218139 A1 HK 1218139A1 HK 16106057 A HK16106057 A HK 16106057A HK 1218139 A1 HK1218139 A1 HK 1218139A1
Authority
HK
Hong Kong
Prior art keywords
cell compositions
reprogrammed cells
compositions derived
cell culture
dedifferentiated reprogrammed
Prior art date
Application number
HK16106057.9A
Other languages
English (en)
Chinese (zh)
Inventor
Alan D. Agulnick
Olivia Kelly
Yuki OHI
Allan Robins
Thomas Schultz
Original Assignee
Viacyte, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US13/761,078 external-priority patent/US9109245B2/en
Application filed by Viacyte, Inc. filed Critical Viacyte, Inc.
Publication of HK1218139A1 publication Critical patent/HK1218139A1/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0012—Cell encapsulation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0676—Pancreatic cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/11—Epidermal growth factor [EGF]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/70—Enzymes
    • C12N2501/72—Transferases [EC 2.]
    • C12N2501/727—Kinases (EC 2.7.)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
    • C12N2506/45—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from artificially induced pluripotent stem cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Diabetes (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
HK16106057.9A 2013-02-06 2014-02-06 去分化的重新編程細胞所衍生的細胞組合物 HK1218139A1 (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US13/761,078 2013-02-06
US13/761,078 US9109245B2 (en) 2009-04-22 2013-02-06 Cell compositions derived from dedifferentiated reprogrammed cells
PCT/US2014/015156 WO2014124172A1 (en) 2013-02-06 2014-02-06 Cell compositions derived from dedifferentiated reprogrammed cells

Publications (1)

Publication Number Publication Date
HK1218139A1 true HK1218139A1 (zh) 2017-02-03

Family

ID=50239931

Family Applications (1)

Application Number Title Priority Date Filing Date
HK16106057.9A HK1218139A1 (zh) 2013-02-06 2014-02-06 去分化的重新編程細胞所衍生的細胞組合物

Country Status (8)

Country Link
EP (1) EP2954045A1 (cg-RX-API-DMAC7.html)
JP (5) JP6517702B2 (cg-RX-API-DMAC7.html)
AU (5) AU2014214879A1 (cg-RX-API-DMAC7.html)
CA (2) CA2898431C (cg-RX-API-DMAC7.html)
HK (1) HK1218139A1 (cg-RX-API-DMAC7.html)
IL (6) IL321825A (cg-RX-API-DMAC7.html)
RU (2) RU2754089C2 (cg-RX-API-DMAC7.html)
WO (1) WO2014124172A1 (cg-RX-API-DMAC7.html)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9109245B2 (en) 2009-04-22 2015-08-18 Viacyte, Inc. Cell compositions derived from dedifferentiated reprogrammed cells
SG11201700874SA (en) 2014-08-04 2017-03-30 Takeda Pharmaceuticals Co Method for proliferation of pancreatic progenitor cells
WO2017180361A1 (en) * 2016-04-14 2017-10-19 Janssen Biotech, Inc. Differentiation of pluripotent stem cells to intestinal midgut endoderm cells
EP3690022B1 (en) * 2016-05-18 2026-03-18 Keio University Cell culture medium for culturing organoid, culture method, and organoid
KR102448428B1 (ko) 2017-01-27 2022-09-30 가부시키가이샤 가네카 내배엽계 세포 집단, 및 다능성 세포로부터 3배엽 중 어느 하나의 세포 집단을 제조하는 방법
IL313825B2 (en) 2017-06-14 2025-07-01 Vertex Pharma Devices and methods for administering medications
JP2020527956A (ja) * 2017-07-21 2020-09-17 センマ・セラピューティクス・インコーポレーテッド 幹細胞由来の膵臓ベータ細胞の再凝集
WO2019169351A1 (en) 2018-03-02 2019-09-06 Semma Therapeutics, Inc. Methods of enhancing stem cell differentiation into beta cells
CN112912490B (zh) * 2018-08-03 2023-12-26 千纸鹤治疗公司 细胞制造方法
TWI862513B (zh) * 2018-09-19 2024-11-21 日商千紙鶴治療公司 包含胰島素產生細胞之細胞集團、包含該細胞集團之醫藥、其用途及製造方法
AU2020282355B2 (en) 2019-05-31 2023-11-02 Viacyte, Inc. A biocompatible membrane composite
US12310830B2 (en) 2019-05-31 2025-05-27 W. L. Gore & Associates, Inc. Biocompatible membrane composite
CA3257300A1 (en) 2019-05-31 2025-06-12 W. L. Gore & Associates, Inc. Cell encapsulation devices with controlled oxygen diffusion distances
EP3975926A1 (en) 2019-05-31 2022-04-06 W.L. Gore & Associates, Inc. A biocompatible membrane composite
JP7705448B2 (ja) 2020-07-31 2025-07-09 バーテックス ファーマシューティカルズ インコーポレイテッド 膵内分泌細胞の分化
EP4596675A4 (en) * 2022-09-26 2026-03-11 Univ Kyoto PROCESS FOR THE PRODUCTION OF PANCREATIC ENDODERMAL CELLS

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4794049B2 (ja) * 1999-04-06 2011-10-12 ジェネンテック, インコーポレイテッド 糖尿病治療へのErbBレセプターリガンドの使用
US6759039B2 (en) * 2000-06-30 2004-07-06 Amcyte, Inc. Culturing pancreatic stem cells having a specified, intermediate stage of development
CA2435826A1 (en) * 2001-01-24 2002-08-01 The Government Of The United States Of America Differentiation of stem cells to pancreatic endocrine cells
CA2625883A1 (en) * 2005-10-14 2007-04-26 Regents Of The University Of Minnesota Differentiation of non-embryonic stem cells to cells having a pancreatic phenotype
US20090298169A1 (en) * 2006-06-02 2009-12-03 The University Of Georgia Research Foundation Pancreatic and Liver Endoderm Cells and Tissue by Differentiation of Definitive Endoderm Cells Obtained from Human Embryonic Stems
EP2356227B1 (en) 2008-11-14 2018-03-28 Viacyte, Inc. Encapsulation of pancreatic cells derived from human pluripotent stem cells
ES2849181T3 (es) * 2009-04-22 2021-08-16 Viacyte Inc Composiciones celulares derivadas de células reprogramadas desdiferenciadas
US9109245B2 (en) * 2009-04-22 2015-08-18 Viacyte, Inc. Cell compositions derived from dedifferentiated reprogrammed cells
WO2010129294A2 (en) * 2009-04-27 2010-11-11 Schulz Thomas C Small molecules supporting pluripotent cell growth and methods thereof
EP2436397B1 (en) * 2009-05-29 2017-05-10 Chugai Seiyaku Kabushiki Kaisha Pharmaceutical composition containing antagonist of egf family ligand as component

Also Published As

Publication number Publication date
JP7550830B2 (ja) 2024-09-13
JP2020178694A (ja) 2020-11-05
CA2898431C (en) 2023-10-17
RU2018144412A3 (cg-RX-API-DMAC7.html) 2020-02-14
JP2016506736A (ja) 2016-03-07
IL311689A (en) 2024-05-01
JP2025000625A (ja) 2025-01-07
AU2023202507B2 (en) 2025-12-04
AU2014214879A1 (en) 2015-07-30
RU2015131279A (ru) 2017-03-13
WO2014124172A1 (en) 2014-08-14
IL326919A (en) 2026-05-01
JP2019146578A (ja) 2019-09-05
IL311689B2 (en) 2025-12-01
IL311689B1 (en) 2025-08-01
EP2954045A1 (en) 2015-12-16
AU2023202507A1 (en) 2023-05-11
IL283088A (en) 2021-06-30
IL239953A0 (en) 2015-08-31
AU2019201314B2 (en) 2021-10-14
JP6517702B2 (ja) 2019-05-22
IL239953B (en) 2021-05-31
JP7250731B2 (ja) 2023-04-03
RU2754089C2 (ru) 2021-08-26
JP6721752B2 (ja) 2020-07-15
IL290717A (en) 2022-04-01
CA3212301A1 (en) 2014-08-14
RU2675928C2 (ru) 2018-12-25
AU2026201562A1 (en) 2026-03-19
AU2019201314A1 (en) 2019-03-14
RU2018144412A (ru) 2019-03-25
JP2023017838A (ja) 2023-02-07
IL290717B2 (en) 2024-10-01
AU2022200075B2 (en) 2023-02-02
AU2022200075C1 (en) 2023-07-06
CA2898431A1 (en) 2014-08-14
IL290717B1 (en) 2024-06-01
IL283088B (en) 2022-04-01
AU2022200075A1 (en) 2022-02-03
IL321825A (en) 2025-08-01

Similar Documents

Publication Publication Date Title
IL273159A (en) A culture medium preparation, and a method for culturing cells or tissues by using the preparation
WO2010124142A3 (en) Cell compositions derived from dedifferentiated reprogrammed cells
MX375786B (es) Biosintesis microbiana de ergotioneina.
WO2016012544A3 (en) Enhanced reprogramming to ips cells
EP3344755A4 (en) PREPARATION SYSTEM FOR PLURIPOTENTE STEM CELLS AND METHOD FOR THE PRODUCTION OF INDUCED PLURIPOTENTAL STEM CELLS
UA118328C2 (uk) Спосіб інтегрування екзогенних послідовностей у геном рослинної клітини
WO2012006440A3 (en) Endothelial cell production by programming
WO2012051210A3 (en) Mesenchymal stem cells and related therapies
EP2904103B8 (en) Method for preparing induced pluripotent stem cells and its applications
MY169357A (en) Methods for additive manufacturing of implant components
MY170720A (en) Antibody formulations
EP3070163A4 (en) Method for preparing induced pluripotent stem cell, composition used in method, and uses thereof
EP3060650A4 (en) Culturing pluripotent stem cells
HK1222205A1 (zh) 由多能干细胞产生的光感受器和光感受器袓细胞
WO2011130402A3 (en) Hepatocyte production by forward programming
NZ701791A (en) Cell culture compositions and methods for polypeptide production
SG10201809452RA (en) Cell culture compositions with antioxidants and methods for polypeptide production
AU2013225816A8 (en) Compositions and methods for treating Type III Gaucher Disease
WO2012019002A3 (en) Somatic stem cells
EP3263697A4 (en) Culture medium for culturing mesenchymal stem cell, method for culturing mesenchymal stem cell, and mesenchymal stem cell
EP3048169A4 (en) Method for preparing pluripotent stem cells
MX2015011781A (es) Medio de cultivo celular y metodos de produccion de anticuerpos.
WO2013188469A3 (en) Pathways characterization of cells
WO2014027176A3 (en) Stem cell culture method
SG11201507091SA (en) Isolated discogenic cells, methods of using, and methods of preparing same from mammalian tissue